Qiagen N.V.
QGEN
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magneticā¦ read more
Healthcare
Diagnostics & Research
30 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$42.50
Price+0.88%
$0.37
1Y
Price
Market Cap
$8.766b
Mid
Price/Earnings 3y Avg5y Avg
17.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+26.6%
EBITDA Margin+19.3%
Net Profit Margin+29.5%
Free Cash Flow Margin+26.6%
EBITDA Margin+19.3%
Net Profit Margin+29.5%
Free Cash Flow MarginRevenue
$2.100b
+0.5%
1y CAGR+2.3%
3y CAGR-0.4%
5y CAGREarnings
$409.316m
-3.7%
1y CAGR+109.7%
3y CAGR+77.4%
5y CAGREPS
$1.95
-4.4%
1y CAGR+118.5%
3y CAGR+84.0%
5y CAGRBook Value
$3.358b
$5.889b
Assets$2.531b
Liabilities$1.644b
DebtDebt to Assets
27.9%
2.2x
Debt to EBITDAFree Cash Flow
$447.700m
-1.2%
1y CAGR+19.7%
3y CAGR+2.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company